ExodusPoint Capital Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-419,176
Closed -$3.36M 2600
2022
Q1
$3.36M Buy
419,176
+276,148
+193% +$2.44M 0.04% 547
2021
Q4
$1.67M Buy
+143,028
New +$1.71M 0.02% 839

Other funds holding SLGC

ExodusPoint Capital Management's SLGC Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 419,176 shares — an estimated $3.36M sold.

ExodusPoint Capital Management first reported a position in SLGC in Q4 2021 and held it in 2 quarters. The position peaked at $3.36M in Q1 2022. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 419,176 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $3.36M.
  • ExodusPoint Capital Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • ExodusPoint Capital Management's SomaLogic, Inc. Class A Common Stock position peaked at $3.36M in Q1 2022.
  • 135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.